ICU-acquired pneumonia with or without etiologic diagnosis: A comparison of outcomes

Critical Care Medicine

Volumn 41, Issue 9, 2013, Pages 2133-2143

  Giunta, Valeria ^a,b,c   Ferrer, Miquel ^a,b   Esperatti, Mariano ^a,b   Ranzani, Otavio T ^a,b,d   Saucedo, Lina Maria ^a   Bassi, Gianluigi Li ^a,b   Blasi, Francesco ^c   Torres, Antoni ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

ICU; lung; microbiology; nosocomial infection; ventilator associated pneumonia

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; PROCALCITONIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ALCOHOL ABUSE; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; ASPERGILLUS; ASPIRATION; BLOOD CULTURE; CHRONIC KIDNEY FAILURE; CITROBACTER; CLINICAL FEATURE; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; ENTEROBACTER; ENTEROBACTERIACEAE; ESCHERICHIA COLI; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; IN VITRO STUDY; INFLAMMATION; INTENSIVE CARE UNIT; INTUBATION; KLEBSIELLA; LEUKOCYTOSIS; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MORAXELLA CATARRHALIS; MORGANELLA MORGANII; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PLEURA FLUID; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEUS; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; SEPTIC SHOCK; SERRATIA; SMOKING HABIT; STENOTROPHOMONAS MALTOPHILIA; STREPTOCOCCUS PNEUMONIAE; TEACHING HOSPITAL; TRACHEAL ASPIRATION PROCEDURE; TREATMENT DURATION; UNIVERSITY HOSPITAL; VENTILATOR ASSOCIATED PNEUMONIA;

AGED; BIOLOGICAL MARKERS; CROSS INFECTION; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MEDICAL AUDIT; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PNEUMONIA, BACTERIAL; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 84883655333     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31828a453b     Document Type: Article

References (50)

1. American Thoracic Society, Infectious Diseases Society of America: Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171:388-416
2. Esperatti M, Ferrer M, Theessen A, et al: Nosocomial pneumonia in the intensive care unit acquired during mechanical ventilation or not. Am J Respir Crit Care Med 2010; 182:1533-1539
3. Koulenti D, Lisboa T, Brun-Buisson C, et al: Spectrum of practice in the diagnosis of nosocomial pneumonia in patients requiring mechanical ventilation in European intensive care units. Crit Care Med 2009; 37:2360-2368
4. Burgmann H, Hiesmayr JM, Savey A, et al: Impact of nosocomial infections on clinical outcome and resource consumption in critically ill patients. Intensive Care Med 2010; 36:1597-1601
5. Bekaert M, Timsit JF, Vansteelandt S, et al: Attributable mortality of ventilator-associated pneumonia: A reappraisal using causal analysis. Am J Respir Crit Care Med 2011; 184:1133-1139
6. Celis R, Torres A, Gatell JM, et al: Nosocomial pneumonia: A multivariate analysis of risk and prognosis. Chest 1988; 93:318-324
7. Luna CM, Vujacich P, Niederman MS, et al: Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 1997; 111:676-685
8. Kollef MH, Ward S: The influence of mini-BAL cultures on patient outcomes: Implications for the antibiotic management of ventilatorassociated pneumonia. Chest 1998; 113:412-420
9. Alvarez-Lerma F: Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group. Intensive Care Med 1996; 22:387-394
10. Torres A, Ewig S, Lode H, et al: Defining, treating and preventing hospital acquired pneumonia: European perspective. Intensive Care Med 2009; 35:9-29
11. Chastre J, Fagon JY: Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 165:867-903
12. Hubmayr RD: Statement of the 4th International Consensus Conference in Critical Care on ICU-Acquired Pneumonia-Chicago, Illinois, May 2002. Intensive Care Med 2002; 28:1521-1536
13. Schleupner CJ, Cobb DK: A study of the etiologies and treatment of nosocomial pneumonia in a community-based teaching hospital. Infect Control Hosp Epidemiol 1992; 13:515-525
14. Souweine B, Veber B, Bedos JP, et al: Diagnostic accuracy of protected specimen brush and bronchoalveolar lavage in nosocomial pneumonia: Impact of previous antimicrobial treatments. Crit Care Med 1998; 26:236-244
15. Hilbert G, Gruson D, Vargas F, et al: Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 2001; 344:481-487
16. Fàbregas N, Ewig S, Torres A, et al: Clinical diagnosis of ventilator associated pneumonia revisited: Comparative validation using immediate post-mortem lung biopsies. Thorax 1999; 54:867-873
17. Woodhead MA, Torres A: Definition and classification of communityacquired and nosocomial pneumonias. In: Pneumonia. Torres A, Woodhead M (Eds). Sheffield, UK, European Respiratory Society Journals, 1997, pp 1-12
18. Luna CM, Blanzaco D, Niederman MS, et al: Resolution of ventilatorassociated pneumonia: Prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome. Crit Care Med 2003; 31:676-682
19. Meduri GU, Chastre J. The standardization of bronchoscopic techniques for ventilator-associated pneumonia. Chest 1992; 102:557S-564S
20. Kollef MH, Bock KR, Richards RD, et al: The safety and diagnosis accuracy of minibronchoalveolar lavage in patients with suspected ventilator associated pneumonia. Ann Intern Med 1995; 122:743-748
21. Ruiz M, Torres A, Ewig S, et al: Noninvasive versus invasive microbial investigation in ventilator-associated pneumonia: Evaluation of outcome. Am J Respir Crit Care Med 2000; 162:119-125
22. van Saene HK, Petros AJ, Ramsay G, et al: All great truths are iconoclastic: Selective decontamination of the digestive tract moves from heresy to level 1 truth. Intensive Care Med 2003; 29:677-690
23. Ioanas M, Cavalcanti M, Ferrer M, et al: Hospital-acquired pneumonia: Coverage and treatment adequacy of current guidelines. Eur Respir J 2003; 22:876-882
24. Valencia AM, Torres MA, Insausti OJ, et al: [Diagnostic value of quantitative cultures of endotracheal aspirate in ventilator-associated pneumonia: A multicenter study]. Arch Bronconeumol 2003; 39:394-399
25. Murray PR, Baron EJO, Pfaller MA, et al: Manual of Clinical Microbiology. 6th ed. Washington, DC, American Society for Microbiology, 1995
26. Heyland DK, Dodek P, Muscedere J, et al: Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia. Crit Care Med 2008; 36:737-744
27. Ioanas M, Ferrer M, Cavalcanti M et al: Causes and predictors of non-response to treatment of the ICU-acquired pneumonia. Crit Care Med 2004; 32:938-945
28. Menéndez R, Martinez R, Reyes S, et al: Stability in communityacquired pneumonia: One step forward with markers? Thorax 2009; 64:987-992
29. Knaus WA, Draper EA, Wagner DP, et al: APACHE II: A severity of disease classification system. Crit Care Med 1985; 13:818-829
30. Le Gall JR, Lemeshow S, Saulnier F: A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270:2957-2963
31. Vincent JL, Moreno R, Takala J, et al: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22:707-710
32. Dellinger RP, Levy MM, Carlet JM et al: Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36:296-327
33. Bernard GR, Artigas A, Brigham KL, et al: The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149(3 Pt 1):818-824
34. Kollef MH, Kollef KE: Antibiotic utilization and outcomes for patients with clinically suspected ventilator-associated pneumonia and negative quantitative BAL culture results. Chest 2005; 128:2706-2713
35. Ibrahim EH, Ward S, Sherman G, et al: A comparative analysis of patients with early-onset vs late-onset nosocomial pneumonia in the ICU setting. Chest 2000; 117:1434-1442
36. Meduri GU, Mauldin GL, Wunderink RG, et al: Causes of fever and pulmonary densities in patients with clinical manifestations of ventilator-associated pneumonia. Chest 1994; 106:221-235
37. Ewig S, Torres A, Angeles Marcos M, et al: Factors associated with unknown aetiology in patients with community-acquired pneumonia. Eur Respir J 2002; 20:1254-1262
38. Luyt CE, Combes A, Deback C, et al: Herpes simplex virus lung infection in patients undergoing prolonged mechanical ventilation. Am J Respir Crit Care Med 2007; 175:935-942
39. Daubin C, Vincent S, Vabret A, et al: Nosocomial viral ventilatorassociated pneumonia in the intensive care unit: A prospective cohort study. Intensive Care Med 2005; 31:1116-1122
40. Kalil AC, Florescu DF: Prevalence and mortality associated with cytomegalovirus infection in nonimmunosuppressed patients in the intensive care unit. Crit Care Med 2009; 37:2350-2358
41. Papazian L, Doddoli C, Chetaille B, et al: A contributive result of openlung biopsy improves survival in acute respiratory distress syndrome patients. Crit Care Med 2007; 35:755-762
42. Taori G, Ho KM, George C, et al: Landmark survival as an end-point for trials in critically ill patients-Comparison of alternative durations of follow-up: An exploratory analysis. Crit Care 2009; 13:R128
43. Timsit JF, Chevret S, Valcke J, et al: Mortality of nosocomial pneumonia in ventilated patients: Influence of diagnostic tools. Am J Respir Crit Care Med 1996; 154:116-123
44. Napolitano LM: Use of severity scoring and stratification factors in clinical trials of hospital-acquired and ventilator-associated pneumonia. Clin Infect Dis 2010; 51(Suppl 1):S67-S80
45. Shan J, Chen HL, Zhu JH: Diagnostic accuracy of clinical pulmonary infection score for ventilator-associated pneumonia: A meta-analysis. Respir Care 2011; 56:1087-1094
46. Ramirez P, Garcia MA, Ferrer M, et al: Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia. Eur Respir J 2008; 31:356-362
47. Ramírez P, Ferrer M, Gimeno R, et al: Systemic inflammatory response and increased risk for ventilator-associated pneumonia: A preliminary study. Crit Care Med 2009; 37:1691-1695
48. Luyt CE, Combes A, Reynaud C, et al: Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia. Intensive Care Med 2008; 34:1434-1440
49. Bauer TT, Montón C, Torres A, et al: Comparison of systemic cytokine levels in patients with acute respiratory distress syndrome, severe pneumonia, and controls. Thorax 2000; 55:46-52
50. Bonten MJ, Froon AH, Gaillard CA, et al: The systemic inflammatory response in the development of ventilator-associated pneumonia. Am J Respir Crit Care Med 1997; 156(4 Pt 1):1105-1113